Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Tagrisso extended disease-free survival regardless of prior adjuvant chemotherapy in early-stage EGFR-mutated lung cancer
-
Datopotamab deruxtecan and Enhertu show promising early clinical activity in patients with advanced non-small cell lung cancer
-
Symbicort Turbuhaler approved in China as an anti-inflammatory reliever in mild asthma
-
Calquence approved in Japan for the treatment of relapsed or refractory chronic lymphocytic leukaemia
-
Calquence met primary efficacy endpoint in head-to-head trial against ibrutinib in chronic lymphocytic leukaemia
-
Enhertu approved in the EU for the treatment of HER2-positive metastatic breast cancer
-
Enhertu approved in the US for the treatment of patients with previously treated HER2-positive advanced gastric cancer
-
Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer
-
AstraZeneca to showcase transformative data across diverse pipeline at World Conference on Lung Cancer
-
Serum Institute of India obtains emergency use authorisation in India for AstraZeneca’s COVID-19 vaccine
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
